Article Details

Dr Boreham's Crucible: Will AstraZeneca cash put Starpharma on a rocket back to all-time highs?

Retrieved on: 2022-06-05 12:56:53

Tags for this article:

Click the tags to see associated articles and topics

Dr Boreham's Crucible: Will AstraZeneca cash put Starpharma on a rocket back to all-time highs?. View article details on hiswai:

Excerpt

Starpharma has a chunky $300m valuation that looks reasonable considering AstraZeneca is likely to spend $US100m on trials.

Article found on: stockhead.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up